"Gln" redirects here. For other uses, see GLN (disambiguation).
Not to be confused with Glutamic acid or Glutaric acid.
Glutamine
Skeletal formula of L-glutamine
Ball-and-stick model
Space-filling model
Names
IUPAC name
Glutamine
Other names
L-Glutamine  (levo)glutamide  2,5-Diamino-5-oxopentanoic acid 2-Amino-4-carbamoylbutanoic acidEndari[1]
Identifiers
CAS Number
56-85-9 Y
3D model (JSmol)
Interactive imageZwitterion: Interactive image
Abbreviations
Gln, Q
ChEBI
CHEBI:18050 Y
ChEMBL
ChEMBL930 Y
ChemSpider
5746 Y
DrugBank
DB00130 Y
ECHA InfoCard
100.000.266 
EC Number
200-292-1
IUPHAR/BPS
723
KEGG
C00303 Y
PubChem CID
5961
UNII
0RH81L854J Y
CompTox Dashboard (EPA)
DTXSID1023100 
InChI
InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1 YKey: ZDXPYRJPNDTMRX-VKHMYHEASA-N Y
SMILES
O=C(N)CCC(N)C(=O)OZwitterion: O=C(N)CCC([NH3+])C(=O)[O-]
Properties[2]
Chemical formula
C5H10N2O3
Molar mass
146.146 g mol 1
Melting point
decomposes around 185 C
Solubility in water
soluble
Acidity (pKa)
2.2 (carboxyl), 9.1 (amino)
Chiral rotation ([ ]D)
+6.5  (H2O, c = 2)
Pharmacology
ATC code
A16AA03 (WHO) 
Supplementary data page
Glutamine (data page)
Except where otherwise noted, data are given for materials in their standard state (at 25 C [77 F], 100 kPa).
Infobox references
Chemical compound
L-glutamine oral powderClinical dataTrade namesEndari, NutrestoreAHFS/Drugs.comMonographMedlinePlusa617035License data
US DailyMed: Glutamine
Routes ofadministrationBy mouthDrug classGastrointestinal agentATC codeA16AA03 (WHO) Legal statusLegal status
US:  -only
Identifiers
IUPAC name
(S)-2,5-diamino-5-oxopentanoic acid
CAS Number56-85-9PubChem CID5961DrugBankDB00130ChemSpider5746UNII0RH81L854JKEGGD00015C00064ChEBICHEBI:58359ChEMBLChEMBL930PDB ligandGLN (PDBe, RCSB PDB)CompTox Dashboard (EPA)DTXSID1023100 ECHA InfoCard100.000.266 Chemical and physical dataFormulaC5H10N2O3Molar mass146.146 g mol 13D model (JSmol)Interactive image
SMILES
C(CC(=O)N)C(C(=O)O)N
InChI
InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1Key:ZDXPYRJPNDTMRX-VKHMYHEASA-N
Data pageGlutamine (data page)
Glutamine (symbol Gln or Q)[4] is an  -amino acid that is used in the biosynthesis of proteins.  Its side chain is similar to that of glutamic acid, except the carboxylic acid group is replaced by an amide. It is classified as a charge-neutral, polar amino acid.  It is non-essential and conditionally essential in humans, meaning the body can usually synthesize sufficient amounts of it, but in some instances of stress, the body's demand for glutamine increases, and glutamine must be obtained from the diet.[5][6] It is encoded by the codons CAA and CAG.
In human blood, glutamine is the most abundant free amino acid.[7]
The dietary sources of glutamine include especially the protein-rich foods like beef, chicken, fish, dairy products, eggs, vegetables like beans, beets, cabbage, spinach, carrots, parsley, vegetable juices and also in wheat, papaya, Brussels sprouts, celery, kale and fermented foods like miso.
Functions[edit]
Glutamine plays a role in a variety of biochemical functions:
Protein synthesis, as any other of the 20 proteinogenic amino acids
Lipid synthesis, especially by cancer cells.[8]
Regulation of acid-base balance in the kidney by producing ammonium[9]
Cellular energy, as a source, next to glucose[10]
Nitrogen donation for many anabolic processes, including the synthesis of purines[7]
Carbon donation, as a source, refilling the citric acid cycle[11]
Nontoxic transporter of ammonia in the blood circulation.[12]
Integrity of healthy intestinal mucosa, though small randomized trials have shown no benefit in Crohn s disease.[13]
Roles in metabolism and cancer[edit]
Cancer cells rely on glutamine metabolism as carbon and nitrogen sources. Glutamine level in the blood serum is the highest among other amino acids[14] and is essential for many cellular functions.
Studies have indicated the importance of glutamine in certain tumors. For example, the inhibition of glutamine metabolism was reported to prevent growth of several tumors such as breast, liver, kidney and T-cell lymphoblastic leukemia.[15]
Precursor[edit]
Glutamine maintains redox balance by participating in glutathione synthesis and contributing to anabolic processes such as lipid synthesis by reductive carboxylation.[16]
Glutamine also preserves nitrogen availability for synthesis of nucleotides and non-essential amino acids.[17] One of the most important functions of glutamine is its ability to be converted into  -KG, which helps to maintain the flow of the tricarboxylic acid cycle, generating ATPs.[18]
Production[edit]
Glutamine is produced industrially using mutants of Brevibacterium flavum, which gives ca. 40 g/L in 2 days using glucose as a carbon source.[19]
Glutamine is synthesized by the enzyme glutamine synthetase from glutamate and ammonia. The most relevant glutamine-producing tissue is the muscle mass, accounting for about 90% of all glutamine synthesized. Glutamine is also released, in small amounts, by the lungs and brain.[20] Although the liver is capable of relevant glutamine synthesis, its role in glutamine metabolism is more regulatory than producing, since the liver takes up large amounts of glutamine derived from the gut.[7]
Consumers[edit]
The most eager consumers of glutamine are the cells of intestines,[7] the kidney cells for the acid-base balance, activated immune cells,[21] and many cancer cells.[8][11][22]
Uses[edit]
Nutrition[edit]
Glutamine is the most abundant naturally occurring, nonessential amino acid in the human body, and one of the few amino acids that can directly cross the blood brain barrier.[7] Humans obtain glutamine through catabolism of proteins in foods they eat.[23] In states where tissue is being built or repaired, like growth of babies, or healing from wounds or severe illness, glutamine becomes conditionally essential.[23]
Sickle cell disease[edit]
In 2017, the U.S. Food and Drug Administration (FDA) approved L-glutamine oral powder, marketed as Endari, to reduce severe complications of sickle cell disease in people aged five years and older with the disorder.[1]
The safety and efficacy of L-glutamine oral powder were studied in a randomized trial of subjects ages five to 58 years old with sickle cell disease who had two or more painful crises within the 12 months prior to enrollment in the trial.[1] Subjects were assigned randomly to treatment with L-glutamine oral powder or placebo, and the effect of treatment was evaluated over 48 weeks.[1] Subjects who were treated with L-glutamine oral powder experienced fewer hospital visits for pain treated with a parenterally administered narcotic or ketorolac (sickle cell crises), on average, compared to subjects who received a placebo (median 3 vs. median 4), fewer hospitalizations for sickle cell pain (median 2 vs. median 3), and fewer days in the hospital (median 6.5 days vs. median 11 days).[1]  Subjects who received L-glutamine oral powder also had fewer occurrences of acute chest syndrome (a life-threatening complication of sickle cell disease) compared with patients who received a placebo (8.6 percent vs. 23.1 percent).[1]
Common side effects of L-glutamine oral powder include constipation, nausea, headache, abdominal pain, cough, pain in the extremities, back pain and chest pain.[1]
L-glutamine oral powder received orphan drug designation.[1] The FDA granted the approval of Endari to Emmaus Medical Inc.[1]
Medical food[edit]
Glutamine is marketed as medical food and is prescribed when a medical professional believes a person in their care needs supplementary glutamine due to metabolic demands beyond what can be met by endogenous synthesis or diet.[24]
Safety[edit]
Glutamine is safe in adults and in preterm infants.[25] Although glutamine is metabolized to glutamate and ammonia, both of which have neurological effects, their concentrations are not increased much, and no adverse neurological effects were detected.[25] The observed safe level for supplemental L-glutamine in normal healthy adults is 14 g/day.[26]
Adverse effects of glutamine have been prescribed for people receiving home parenteral nutrition and those with liver-function abnormalities.[27]
Although glutamine has no effect on the proliferation of tumor cells, it is still possible that glutamine supplementation may be detrimental in some cancer types.[28]
Ceasing glutamine supplementation in people adapted to very high consumption may initiate a withdrawal effect, raising the risk of health problems such as infections or impaired integrity of the intestine.[28]
Structure[edit]
Glutamine can exist in either of two enantiomeric forms, L-glutamine and D-glutamine.  The L-form is found in nature.  Glutamine contains an  -amino group which is in the protonated  NH3+ form under biological conditions and a carboxylic acid group which is in the deprotonated  COO  form, known as carboxylate, under physiological conditions.
 Glutamine zwitterionic forms at neutral pH: L-glutamine (left) and D-glutamine
Research[edit]
 Consequences of glutamine depletion in critically ill individuals[29]
Glutamine mouthwash may be useful to prevent oral mucositis in people undergoing chemotherapy but intravenous glutamine does not appear useful to prevent mucositis in the GI tract.[30]
Glutamine supplementation was thought to have potential to reduce complications in people who are critically ill or who have had abdominal surgery but this was based on poor quality clinical trials.[31] Supplementation does not appear to be useful in adults or children with Crohn's disease or inflammatory bowel disease, but clinical studies as of 2016 were underpowered.[13] Supplementation does not appear to have an effect in infants with significant problems of the stomach or intestines.[32]
Some athletes use L-glutamine as supplement. Studies support the positive effects of the chronic oral administration of the supplement on the injury and inflammation induced by intense aerobic and exhaustive exercise, but the effects on muscle recovery from weight training are unclear.[33]
See also[edit]
Isoglutamine
References[edit]
^ a b c d e f g h i "FDA approves new treatment for sickle cell disease". U.S. Food and Drug Administration (FDA) (Press release). 7 July 2017. Retrieved 10 July 2017.  This article incorporates text from this source, which is in the public domain.
^ Weast, Robert C., ed. (1981). CRC Handbook of Chemistry and Physics (62nd ed.). Boca Raton, FL: CRC Press. p. C-311. ISBN 0-8493-0462-8..
^ "Glutamine Use During Pregnancy". Drugs.com. 30 September 2019. Retrieved 23 April 2020.
^ "Nomenclature and Symbolism for Amino Acids and Peptides". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008. Retrieved 5 March 2018.
^ Food and Nutrition Board of the Institute of Medicine (2006). "Protein and Amino Acids".  In Otten JJ, Hellwig JP, Meyers LD (eds.). Dietary Reference Intakes: The Essential Guide to Nutrient Requirements (PDF). Washington, D.C.: National Academies Press. p. 147. ISBN 978-0-309-10091-5. Archived from the original (PDF) on 9 April 2014.
^ Lacey JM, Wilmore DW (August 1990). "Is glutamine a conditionally essential amino acid?". Nutrition Reviews. 48 (8): 297 309. doi:10.1111/j.1753-4887.1990.tb02967.x. PMID 2080048.
^ a b c d e Brosnan JT (June 2003). "Interorgan amino acid transport and its regulation". The Journal of Nutrition. 133 (6 Suppl 1): 2068S 2072S. doi:10.1093/jn/133.6.2068S. PMID 12771367.
^ a b Corbet C, Feron O (July 2015).  Corbet C, Feron O (eds.). "Metabolic and mind shifts: from glucose to glutamine and acetate addictions in cancer". Current Opinion in Clinical Nutrition and Metabolic Care. 18 (4): 346 353. doi:10.1097/MCO.0000000000000178. PMID 26001655. S2CID 1478014.
^ Hall JE, Guyton AC (2006). Textbook of Medical Physiology (11th ed.). St. Louis, Mo: Elsevier Saunders. p. 393. ISBN 978-0-7216-0240-0.
^ Aledo JC (July 2004). "Glutamine breakdown in rapidly dividing cells: waste or investment?". BioEssays. 26 (7): 778 785. doi:10.1002/bies.20063. PMID 15221859.
^ a b Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y (July 2007). "Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells". The Journal of Cell Biology. 178 (1): 93 105. doi:10.1083/jcb.200703099. PMC 2064426. PMID 17606868.
^ Dabrowska K, Skowronska K, Popek M, Obara-Michlewska M, Albrecht J, Zielinska M (2018). "Roles of Glutamate and Glutamine Transport in Ammonia Neurotoxicity: State of the Art and Question Marks". Endocrine, Metabolic & Immune Disorders Drug Targets. 18 (4): 306 315. doi:10.2174/1871520618666171219124427. PMID 29256360. S2CID 26569656.
^ a b Yamamoto T, Shimoyama T, Kuriyama M (April 2017). "Dietary and enteral interventions for Crohn's disease". Current Opinion in Biotechnology. 44: 69 73. doi:10.1016/j.copbio.2016.11.011. PMID 27940405.
^ Welbourne TC (March 1979). "Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney". Canadian Journal of Biochemistry. 57 (3): 233 237. doi:10.1139/o79-029. PMID 436006.
^ Abu Aboud O, Habib SL, Trott J, Stewart B, Liang S, Chaudhari AJ,  et al. (December 2017). "Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging". Cancer Research. 77 (23): 6746 6758. doi:10.1158/0008-5472.CAN-17-0930. PMC 5791889. PMID 29021138.
^ Jiang L, Shestov AA, Swain P, Yang C, Parker SJ, Wang QA,  et al. (April 2016). "Reductive carboxylation supports redox homeostasis during anchorage-independent growth". Nature. 532 (7598): 255 258. Bibcode:2016Natur.532..255J. doi:10.1038/nature17393. PMC 4860952. PMID 27049945.
^ DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB (December 2007). "Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis". Proceedings of the National Academy of Sciences of the United States of America. 104 (49): 19345 19350. Bibcode:2007PNAS..10419345D. doi:10.1073/pnas.0709747104. PMC 2148292. PMID 18032601.
^ DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (January 2008). "The biology of cancer: metabolic reprogramming fuels cell growth and proliferation". Cell Metabolism. 7 (1): 11 20. doi:10.1016/j.cmet.2007.10.002. PMID 18177721.
^ Drauz K, Grayson I, Kleemann A, Krimmer HP, Leuchtenberger W, Weckbecker C (2007). "Amino Acids". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a02_057.pub2.
^ Newsholme P, Lima MM, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, Curi R (February 2003). "Glutamine and glutamate as vital metabolites". Brazilian Journal of Medical and Biological Research = Revista Brasileira de Pesquisas Medicas e Biologicas. 36 (2): 153 163. doi:10.1590/S0100-879X2003000200002. PMID 12563517.
^ Newsholme P (September 2001). "Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?". The Journal of Nutrition. 131 (9 Suppl): 2515S 2522S, discussion 2522S 4S. doi:10.1093/jn/131.9.2515S. PMID 11533304.
^ Fernandez-de-Cossio-Diaz J, Vazquez A (October 2017). "Limits of aerobic metabolism in cancer cells". Scientific Reports. 7 (1): 13488. Bibcode:2017NatSR...713488F. doi:10.1038/s41598-017-14071-y. PMC 5647437. PMID 29044214.
^ a b Watford M (September 2015). "Glutamine and glutamate: Nonessential or essential amino acids?". Animal Nutrition. 1 (3): 119 122. doi:10.1016/j.aninu.2015.08.008. PMC 5945979. PMID 29767158.
^ "GlutaSolve, NutreStore, SYMPT-X G.I., SYMPT-X Glutamine (glutamine) Drug Side Effects, Interactions, and Medication Information on eMedicineHealth". eMedicineHealth. Retrieved 24 January 2017.
^ a b Garlick PJ (September 2001). "Assessment of the safety of glutamine and other amino acids". The Journal of Nutrition. 131 (9 Suppl): 2556S 2561S. doi:10.1093/jn/131.9.2556S. PMID 11533313.
^ Shao A, Hathcock JN (April 2008). "Risk assessment for the amino acids taurine, L-glutamine and L-arginine". Regulatory Toxicology and Pharmacology. 50 (3): 376 399. doi:10.1016/j.yrtph.2008.01.004. PMID 18325648.
^ Buchman AL (July 2001). "Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data". The American Journal of Clinical Nutrition. 74 (1): 25 32. doi:10.1093/ajcn/74.1.25. PMID 11451714.
^ a b Holecek M (September 2013). "Side effects of long-term glutamine supplementation". Journal of Parenteral and Enteral Nutrition. 37 (5): 607 616. doi:10.1177/0148607112460682. PMID 22990615.
^ Stehle P, Kuhn KS (2015). "Glutamine: an obligatory parenteral nutrition substrate in critical care therapy". BioMed Research International. 2015: 545467. doi:10.1155/2015/545467. PMC 4606408. PMID 26495301.
^ Berretta M, Michieli M, Di Francia R, Cappellani A, Rupolo M, Galvano F,  et al. (January 2013). "Nutrition in oncologic patients during antiblastic treatment". Frontiers in Bioscience. 18 (1): 120 132. doi:10.2741/4091. PMID 23276913.
^ Tao KM, Li XQ, Yang LQ, Yu WF, Lu ZJ, Sun YM, Wu FX (September 2014). "Glutamine supplementation for critically ill adults". The Cochrane Database of Systematic Reviews (9): CD010050. doi:10.1002/14651858.CD010050.pub2. PMC 6517119. PMID 25199493.
^ Moe-Byrne T, Brown JV, McGuire W (April 2016).  McGuire W (ed.). "Glutamine supplementation to prevent morbidity and mortality in preterm infants". The Cochrane Database of Systematic Reviews. 4: CD001457. doi:10.1002/14651858.CD001457.pub6. PMC 7055588. PMID 27089158.
^ Raizel R, Tirapegui J (5 December 2018). "Role of glutamine, as free or dipeptide form, on muscle recovery from resistance training: a review study". Nutrire. 43 (1): 28. doi:10.1186/s41110-018-0087-9. ISSN 2316-7874. S2CID 81105808.
External links[edit]
Glutamine spectra acquired through mass spectroscopy
"Glutamine". Drug Information Portal. U.S. National Library of Medicine.
vteOther alimentary tract and metabolism products (A16)Amino acids and derivatives
Ademetionine
Betaine
Carglumic acid
Cysteamine
Levocarnitine
Levoglutamide
Metreleptin
Enzymes
Amino acids: phenylalanine ammonia-lyase (Pegvaliase)
Carbohydrate metabolism: sucrase (Sacrosidase)
alpha-glucosidase (Alglucosidase alfa, Avalglucosidase alfa, Cipaglucosidase alfa)
Glycolipid/sphingolipid: glucocerebrosidase (Alglucerase
Imiglucerase
Taliglucerase alfa
Velaglucerase alfa)
alpha-galactosidase (Agalsidase alfa
Agalsidase beta
Pegunigalsidase alfa)
Glycosaminoglycan: iduronidase (Laronidase)
arylsulfatase B (Galsulfase)
iduronate-2-sulfatase (Idursulfase)
Lipid: lysosomal lipase (Sebelipase alfa)
Phosphate: Asfotase alfa
Other
Anethole trithione
Eliglustat
Givosiran
Glycerol phenylbutyrate
Lumasiran
Miglustat
Nitisinone
Sapropterin
Sodium benzoate
Sodium phenylacetate/sodium benzoate
Sodium phenylbutyrate
Teduglutide
Trientine
Tioctic acid
Triheptanoin
Uridine triacetate
Velmanase alfa
Zinc acetate
vteEncoded (proteinogenic) amino acidsGeneral topics
Protein
Peptide
Genetic code
By propertiesAliphatic
Branched-chain amino acids (Valine
Isoleucine
Leucine)
Methionine
Alanine
Proline
Glycine
Aromatic
Phenylalanine
Tyrosine
Tryptophan
Histidine
Polar, uncharged
Asparagine
Glutamine
Serine
Threonine
Positive charge (pKa)
Lysine ( 10.8)
Arginine ( 12.5)
Histidine ( 6.1)
Pyrrolysine
Negative charge (pKa)
Aspartic acid ( 3.9)
Glutamic acid ( 4.1)
Selenocysteine ( 5.4)
Cysteine ( 8.3)
Tyrosine ( 10.1)
Amino acids types: Encoded (proteins)
Essential
Non-proteinogenic
Ketogenic
Glucogenic
Secondary amino
Imino acids
D-amino acids
Dehydroamino acids
vteDietary supplementsTypes
Bodybuilding supplement
Energy drink
Energy bar
Fatty acids
Herbal supplements
Minerals
Prebiotics
Probiotics (Lactobacillus
Bifidobacterium)
Protein supplements
Vitamins
Vitamins andchemical elements ("minerals")
Retinol (Vitamin A)
B vitamins
Thiamine (B1)
Riboflavin (B2)
Niacin (B3)
Pantothenic acid (B5)
Pyridoxine (B6)
Biotin (B7)
Folic acid (B9)
Cyanocobalamin (B12)
Ascorbic acid (Vitamin C)
Ergocalciferol and Cholecalciferol (Vitamin D)
Tocopherol (Vitamin E)
Naphthoquinone (Vitamin K)
Calcium
Choline
Chromium
Cobalt
Copper
Fluorine
Iodine
Iron
Magnesium
Manganese
Molybdenum
Phosphorus
Potassium
Selenium
Sodium
Sulfur
Zinc
Other common ingredients
AAKG
 -hydroxy  -methylbutyrate
Carnitine
Chondroitin sulfate
Cod liver oil
Copper gluconate
Creatine
Dietary fiber
Echinacea
Ephedra
Fish oil
Folic acid
Ginseng
Glucosamine
Glutamine
Grape seed extract
Guarana
Iron supplements
Japanese honeysuckle
Krill oil
Lingzhi
Linseed oil
Lipoic acid
Milk thistle
Melatonin
Red yeast rice
Royal jelly
Saw palmetto
Spirulina
St John's wort
Taurine
Wheatgrass
Wolfberry
Yohimbine
Zinc gluconate
Related articles
Codex Alimentarius
Enzyte
Hadacol
Herbal tea
Nutraceutical
Multivitamin
Nutrition
vteGABA receptor modulatorsIonotropicGABAA
Agonists: (+)-Catechin
Bamaluzole
Barbiturates (e.g., phenobarbital)
Beta-Alanine
BL-1020
DAVA
Dihydromuscimol
GABA
Gabamide
GABOB
Gaboxadol (THIP)
Homotaurine (tramiprosate, 3-APS)
Ibotenic acid
iso-THAZ
iso-THIP
Isoguvacine
Isomuscimol
Isonipecotic acid
Kojic amine
L-838,417
Lignans (e.g., honokiol)
Methylglyoxal
Monastrol
Muscimol
Nefiracetam
Neuroactive steroids (e.g., allopregnanolone)
Org 20599
PF-6372865
Phenibut
Picamilon
P4S
Progabide
Propofol
Quisqualamine
SL-75102
Taurine
TACA
TAMP
Terpenoids (e.g., borneol)
Thiomuscimol
Tolgabide
ZAPA
Positive modulators (abridged; see here for a full list):  -EMTBL
Alcohols (e.g., drinking alcohol, 2M2B)
Anabolic steroids
Avermectins (e.g., ivermectin)
Barbiturates (e.g., phenobarbital)
Benzodiazepines (e.g., diazepam)
Bromide compounds (e.g., potassium bromide)
Carbamates (e.g., meprobamate)
Carbamazepine
Chloralose
Chlormezanone
Clomethiazole
Dihydroergolines (e.g., ergoloid (dihydroergotoxine))
Etazepine
Etifoxine
Fenamates (e.g., mefenamic acid)
Flavonoids (e.g., apigenin, hispidulin)
Fluoxetine
Flupirtine
Imidazoles (e.g., etomidate)
Kava constituents (e.g., kavain)
Lanthanum
Loreclezole
Monastrol
Neuroactive steroids (e.g., allopregnanolone, cholesterol, THDOC)
Niacin
Niacinamide
Nonbenzodiazepines (e.g.,  -carbolines (e.g., abecarnil), cyclopyrrolones (e.g., zopiclone), imidazopyridines (e.g., zolpidem), pyrazolopyrimidines (e.g., zaleplon))
Norfluoxetine
Petrichloral
Phenols (e.g., propofol)
Phenytoin
Piperidinediones (e.g., glutethimide)
Propanidid
Pyrazolopyridines (e.g., etazolate)
Quinazolinones (e.g., methaqualone)
Retigabine (ezogabine)
ROD-188
Skullcap constituents (e.g., baicalin)
Stiripentol
Sulfonylalkanes (e.g., sulfonmethane (sulfonal))
Topiramate
Valerian constituents (e.g., valerenic acid)
Volatiles/gases (e.g., chloral hydrate, chloroform, diethyl ether, paraldehyde, sevoflurane)
Antagonists: Bicuculline
Coriamyrtin
Dihydrosecurinine
Gabazine (SR-95531)
Hydrastine
Hyenachin (mellitoxin)
PHP-501
Pitrazepin
Securinine
Sinomenine
SR-42641
SR-95103
Thiocolchicoside
Tutin
Negative modulators: 1,3M1B
3M2B
11-Ketoprogesterone
17-Phenylandrostenol
 5IA (LS-193,268)
 -CCB
 -CCE
 -CCM
 -CCP
 -EMGBL
Anabolic steroids
Amiloride
Anisatin
 -Lactams (e.g., penicillins, cephalosporins, carbapenems)
Basmisanil
Bemegride
Bicyclic phosphates (TBPS, TBPO, IPTBO)
BIDN
Bilobalide
Bupropion
CHEB
Chlorophenylsilatrane
Cicutoxin
Cloflubicyne
Cyclothiazide
DHEA
DHEA-S
Dieldrin
(+)-DMBB
DMCM
DMPC
EBOB
Etbicyphat
FG-7142 (ZK-31906)
Fiproles (e.g., fipronil)
Flavonoids (e.g., amentoflavone, oroxylin A)
Flumazenil
Fluoroquinolones (e.g., ciprofloxacin)
Flurothyl
Furosemide
Golexanolone
Iomazenil (123I)
IPTBO
Isopregnanolone (sepranolone)
L-655,708
Laudanosine
Leptazol
Lindane
MaxiPost
Morphine
Morphine-3-glucuronide
MRK-016
Naloxone
Naltrexone
Nicardipine
Nonsteroidal antiandrogens (e.g., apalutamide, bicalutamide, enzalutamide, flutamide, nilutamide)
Oenanthotoxin
Pentylenetetrazol (pentetrazol)
Phenylsilatrane
Picrotoxin (i.e., picrotin, picrotoxinin and dihydropicrotoxinin)
Pregnenolone sulfate
Propybicyphat
PWZ-029
Radequinil
Ro 15-4513
Ro 19-4603
RO4882224
RO4938581
Sarmazenil
SCS
Suritozole
TB-21007
TBOB
TBPS
TCS-1105
Terbequinil
TETS
Thujone
U-93631
Zinc
ZK-93426
GABAA- 
Agonists: BL-1020
CACA
CAMP
Homohypotaurine
GABA
GABOB
Ibotenic acid
Isoguvacine
Muscimol
N4-Chloroacetylcytosine arabinoside
Picamilon
Progabide
TACA
TAMP
Thiomuscimol
Tolgabide
Positive modulators: Allopregnanolone
Alphaxolone
ATHDOC
Lanthanides
Antagonists: (S)-2-MeGABA
(S)-4-ACPBPA
(S)-4-ACPCA
2-MeTACA
3-APMPA
4-ACPAM
4-GBA
cis-3-ACPBPA
CGP-36742 (SGS-742)
DAVA
Gabazine (SR-95531)
Gaboxadol (THIP)
I4AA
Isonipecotic acid
Loreclezole
P4MPA
P4S
SKF-97541
SR-95318
SR-95813
TPMPA
trans-3-ACPBPA
ZAPA
Negative modulators: 5 -Dihydroprogesterone
Bilobalide
Loreclezole
Picrotoxin (picrotin, picrotoxinin)
Pregnanolone
ROD-188
THDOC
Zinc
MetabotropicGABAB
Agonists: 1,4-Butanediol
3-APPA
4-Fluorophenibut
Aceburic acid
Arbaclofen
Arbaclofen placarbil
Baclofen
BL-1020
GABA
Gabamide
GABOB
GBL
GHB
GHBAL
GHV
GVL
Isovaline
Lesogaberan
Phenibut
Picamilon
Progabide
Sodium oxybate
SKF-97,541
SL 75102
Tolgabide
Tolibut
Positive modulators: ADX-71441
BHF-177
BHFF
BSPP
CGP-7930
CGP-13501
GS-39783
rac-BHFF
KK-92A
Antagonists: 2-Hydroxysaclofen
CGP-35348
CGP-46381
CGP-52432
CGP-54626
CGP-55845
CGP-64213
DAVA
Homotaurine (tramiprosate, 3-APS)
Phaclofen
Saclofen
SCH-50911
SKF-97541
Negative modulators: Compound 14
See also
Receptor/signaling modulators 
GABAA receptor positive modulators 
GABA metabolism/transport modulators 
Glutamate receptor modulators
vteIonotropic glutamate receptor modulatorsAMPAR
Agonists: Main site agonists: 5-Fluorowillardiine
Acromelic acid (acromelate)
AMPA
BOAA
Domoic acid
Glutamate
Ibotenic acid
Proline
Quisqualic acid
Willardiine; Positive allosteric modulators: Aniracetam
Cyclothiazide
CX-516
CX-546
CX-614
Farampator (CX-691, ORG-24448)
CX-717
CX-1739
CX-1942
Diazoxide
Hydrochlorothiazide (HCTZ)
IDRA-21
LY-392098
LY-395153
LY-404187
LY-451646
LY-503430
Mibampator (LY-451395)
Nooglutyl
ORG-26576
Oxiracetam
PEPA
Pesampator (BIIB-104, PF-04958242)
Piracetam
Pramiracetam
S-18986
Tulrampator (S-47445, CX-1632)
Antagonists: ACEA-1011
ATPO
Becampanel
Caroverine
CNQX
Dasolampanel
DNQX
Fanapanel (MPQX)
GAMS
Kaitocephalin
Kynurenic acid
Kynurenine
Licostinel (ACEA-1021)
NBQX
PNQX
Selurampanel
Tezampanel
Theanine
Topiramate
YM90K
Zonampanel; Negative allosteric modulators: Barbiturates (e.g., pentobarbital, sodium thiopental)
Cyclopropane
Enflurane
Ethanol (alcohol)
Evans blue
GYKI-52466
GYKI-53655
Halothane
Irampanel
Isoflurane
Perampanel
Pregnenolone sulfate
Sevoflurane
Talampanel; Unknown/unsorted antagonists: Minocycline
KAR
Agonists: Main site agonists: 5-Bromowillardiine
5-Iodowillardiine
Acromelic acid (acromelate)
AMPA
ATPA
Domoic acid
Glutamate
Ibotenic acid
Kainic acid
LY-339434
Proline
Quisqualic acid
SYM-2081; Positive allosteric modulators: Cyclothiazide
Diazoxide
Enflurane
Halothane
Isoflurane
Antagonists: ACEA-1011
CNQX
Dasolampanel
DNQX
GAMS
Kaitocephalin
Kynurenic acid
Licostinel (ACEA-1021)
LY-382884
NBQX
NS102
Selurampanel
Tezampanel
Theanine
Topiramate
UBP-302; Negative allosteric modulators: Barbiturates (e.g., pentobarbital, sodium thiopental)
Enflurane
Ethanol (alcohol)
Evans blue
NS-3763
Pregnenolone sulfate
NMDAR
Agonists: Main site agonists: AMAA
Aspartate
Glutamate
Homocysteic acid (L-HCA)
Homoquinolinic acid
Ibotenic acid
NMDA
Proline
Quinolinic acid
Tetrazolylglycine
Theanine; Glycine site agonists:  -Fluoro-D-alanine
ACBD
ACC (ACPC)
ACPD
AK-51
Apimostinel (NRX-1074)
B6B21
CCG
D-Alanine
D-Cycloserine
D-Serine
DHPG
Dimethylglycine
Glycine
HA-966
L-687414
L-Alanine
L-Serine
Milacemide
Neboglamine (nebostinel)
Rapastinel (GLYX-13)
Sarcosine; Polyamine site agonists: Neomycin
Spermidine
Spermine; Other positive allosteric modulators: 24S-Hydroxycholesterol
DHEA (prasterone)
DHEA sulfate (prasterone sulfate)
Epipregnanolone sulfate
Plazinemdor
Pregnenolone sulfate
SAGE-201
SAGE-301
SAGE-718
Antagonists: Competitive antagonists: AP5 (APV)
AP7
CGP-37849
CGP-39551
CGP-39653
CGP-40116
CGS-19755
CPP
Kaitocephalin
LY-233053
LY-235959
LY-274614
MDL-100453
Midafotel (d-CPPene)
NPC-12626
NPC-17742
PBPD
PEAQX
Perzinfotel
PPDA
SDZ-220581
Selfotel; Glycine site antagonists: 4-Cl-KYN (AV-101)
5,7-DCKA
7-CKA
ACC
ACEA-1011
ACEA-1328
Apimostinel (NRX-1074)
AV-101
Carisoprodol
CGP-39653
CNQX
D-Cycloserine
DNQX
Felbamate
Gavestinel
GV-196771
Harkoseride
Kynurenic acid
Kynurenine
L-689560
L-701324
Licostinel (ACEA-1021)
LU-73068
MDL-105519
Meprobamate
MRZ 2/576
PNQX
Rapastinel (GLYX-13)
ZD-9379; Polyamine site antagonists: Arcaine
Co 101676
Diaminopropane
Diethylenetriamine
Huperzine A
Putrescine; Uncompetitive pore blockers (mostly dizocilpine site): 2-MDP
3-HO-PCP
3-MeO-PCE
3-MeO-PCMo
3-MeO-PCP
4-MeO-PCP
8A-PDHQ
18-MC
 -Endopsychosin
Alaproclate
Alazocine (SKF-10047)
Amantadine
Aptiganel
Argiotoxin-636
Arketamine
ARL-12495
ARL-15896-AR
ARL-16247
Budipine
Coronaridine
Delucemine (NPS-1506)
Dexoxadrol
Dextrallorphan
Dextromethadone
Dextromethorphan
Dextrorphan
Dieticyclidine
Diphenidine
Dizocilpine
Ephenidine
Esketamine
Etoxadrol
Eticyclidine
Fluorolintane
Gacyclidine
Ibogaine
Ibogamine
Indantadol
Ketamine
Ketobemidone
Lanicemine
Levomethadone
Levomethorphan
Levomilnacipran
Levorphanol
Loperamide
Memantine
Methadone
Methorphan
Methoxetamine
Methoxphenidine
Milnacipran
Morphanol
NEFA
Neramexane
Nitromemantine
Noribogaine
Norketamine
Orphenadrine
PCPr
PD-137889
Pethidine (meperidine)
Phencyclamine
Phencyclidine
Propoxyphene
Remacemide
Rhynchophylline
Rimantadine
Rolicyclidine
Sabeluzole
Tabernanthine
Tenocyclidine
Tiletamine
Tramadol; Ifenprodil (NR2B) site antagonists:
Besonprodil
Buphenine (nylidrin)
CO-101244 (PD-174494)
Eliprodil
Haloperidol
Isoxsuprine
Radiprodil (RGH-896)
Rislenemdaz (CERC-301, MK-0657)
Ro 8-4304
Ro 25-6981
Safaprodil
Traxoprodil (CP-101606); NR2A-selective antagonists: MPX-004
MPX-007
TCN-201
TCN-213; Cations: Hydrogen
Magnesium
Zinc; Alcohols/volatile anesthetics/related: Benzene
Butane
Chloroform
Cyclopropane
Desflurane
Diethyl ether
Enflurane
Ethanol (alcohol)
Halothane
Hexanol
Isoflurane
Methoxyflurane
Nitrous oxide
Octanol
Sevoflurane
Toluene
Trichloroethane
Trichloroethanol
Trichloroethylene
Urethane
Xenon
Xylene; Unknown/unsorted antagonists: ARR-15896
Bumetanide
Caroverine
Conantokin
D- AA
Dexanabinol
Flufenamic acid
Flupirtine
FPL-12495
FR-115427
Furosemide
Hodgkinsine
Ipenoxazone (MLV-6976)
MDL-27266
Metaphit
Minocycline
MPEP
Niflumic acid
Pentamidine
Pentamidine isethionate
Piretanide
Psychotridine
Transcrocetin (saffron)
Unsorted: Allosteric modulators: AGN-241751
See also: Receptor/signaling modulators
Metabotropic glutamate receptor modulators
Glutamate metabolism/transport modulators
vteMetabotropic glutamate receptor modulatorsGroup ImGluR1
Agonists: ACPD
DHPG
Glutamate
Ibotenic acid
Quisqualic acid
Ro01-6128
Ro67-4853
Ro67-7476
VU-71
Theanine
Antagonists: BAY 36-7620
CPCCOEt
Cyclothiazide
LY-367,385
LY-456,236
MCPG
NPS-2390
mGluR5
Agonists: ACPD
ADX-47273
CDPPB
CHPG
DFB
DHPG
Glutamate
Ibotenic acid
Quisqualic acid
VU-1545
Antagonists: CTEP
DMeOB
LY-344,545
Mavoglurant
MCPG
NPS-2390
Remeglurant
SIB-1757
SIB-1893; Negative allosteric modulators: AZD9272
Basimglurant
Dipraglurant
Fenobam
GRN-529
MPEP
MTEP
Raseglurant
Group IImGluR2
Agonists: BINA
CBiPES
DCG-IV
Eglumegad
Glutamate
Ibotenic acid
LY-379,268
LY-404,039 (pomaglumetad)
LY-487,379
LY-566,332
MGS-0028
Pomaglumetad methionil (LY-2140023)
Talaglumetad; Positive allosteric modulators: JNJ-40411813 (ADX-71149)
Antagonists: APICA
CECXG
EGLU
HYDIA
LY-307,452
LY-341,495
MCPG
MGS-0039
PCCG-4; Negative allosteric modulators: Decoglurant
RO4491533
mGluR3
Agonists: CBiPES
DCG-IV
Eglumegad
Glutamate
Ibotenic acid
LY-379,268
LY-404,039 (pomaglumetad)
LY-487,379
MGS-0028
Pomaglumetad methionil (LY-2140023)
Talaglumetad
Antagonists: APICA
CECXG
EGLU
HYDIA
LY-307,452
LY-341,495
MCPG
MGS-0039; Negative allosteric modulators: Decoglurant
RO4491533
Group IIImGluR4
Agonists: Glutamate
L-AP4
LSP2-9166
PHCCC
VU-001,171
VU-0155,041; Positive allosteric modulators: Foliglurax
MPEP
Antagonists: CPPG
MAP4
MPPG
MSOP
MTPG
UBP-1112
mGluR6
Agonists: Glutamate
L-AP4
Antagonists: CPPG
MAP4
MPPG
MSOP
MTPG
UBP-1112
mGluR7
Agonists: AMN082
Glutamate
L-AP4
LSP2-9166
Antagonists: CPPG
MAP4
MMPIP
MPPG
MSOP
MTPG
UBP-1112
XAP044; Negative allosteric modulators: ADX71743
mGluR8
Agonists: DCPG
Glutamate
L-AP4; Positive allosteric modulators: AZ12216052
Antagonists: CPPG
MAP4
MPPG
MSOP
MTPG
UBP-1112
See also: Receptor/signaling modulators   Ionotropic glutamate receptor modulators   Glutamate metabolism/transport modulators
Authority control: National 
France
BnF data
Israel
United States
Japan
Portal: Medicine
Retrieved from "https://en.wikipedia.org/w/index.php?title=Glutamine&oldid=1136191980"